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Aim: A case control study was designed to assess whether the prevalence of ACE gene
polymorphism has any role in the development of CAD.
Methods: The study included unrelated 217 cases with CAD and 255 healthy controls. PCR
was done using primers followed by agarose gel electrophoresis for study of different ACE
gene polymorphisms. Multiple logistic regression analysis was carried out to find associ-
ation between studied genotypes and lifestyle as well as biochemical risk factors.
Results: Both DD [OR: 2.16; 95%CI: (60.60e67.40)] and ID [OR: 1.48; 95%CI: (93.28e97.72)]
genotypes of the ACE gene showed significant associations in the development of CAD.
Coexistence of diabetes and hypertension found to be risk modifier of the disease. Tobacco
intake in various forms elevates the risk of the disease among the cases with risk
genotypes.
Conclusion: ID and DD genotypes of ACE gene came out to be predisposing factors for the
CAD cases in our study population.
Copyright ª 2012, Cardiological Society of India. All rights reserved.1. Introduction with heart disease will be in India.2 Ischaemic heart diseaseTheWorld Health Organization (WHO) reports that in the year
2005 cardiovascular diseases (CVD) caused 17.5 million (30%)
of the 58 million deaths that occurred worldwide.1 It has been
projected that by the year 2010, 60% of the world’s patientslecular Biologist, Institut
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l.com (S. Chakrabarti).
2012, Cardiological Socie(IHD), myocardial ischaemia (MI), is a disease resulting
reduced blood supply to the heart muscle, usually due to
coronary artery disease (atherosclerosis of the coronary
arteries). Coronary artery disease (CAD) is a multifactorial
disorder that is thought to result from an interaction betweene of Haematology and Transfusion Medicine, Medical College, 88,
95; fax: þ91 33 24754351.
ty of India. All rights reserved.
Fig. 1 e Patterns of studied ACE polymorphisms. Lane 1:
DD genotype (190 bp). Lane 2, 4: II genotype (490 bp). Lane
3: 50 bp molecular weight marker (Bangalore Genei). Lane
5, 6: ID genotype (490 bp, 190 bp).
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smoking and physical activity.3 Major risk factors are seden-
tary lifestyle, cigarette/bidi smoking, alcohol intake hyper-
tension, high Low Density Lipid (LDL) cholesterol, low High
Density Lipid (HDL) cholesterol and diabetes mellitus. Other
factors that influence CHD risk are obesity, family history of
premature CHD, insulin resistance, hypertriglyceridaemia,
small dense LDL particles, lipoprotein A, serum homocysteine
and abnormalities in several coagulation factors. Interactions
between genetic and environmental factors influence
progression of pathological processes clinical characteristics
of disease and susceptibility to therapeutic treatment.4
Genetic factors help in explaining the molecular basis of the
disorder and in designing prevention and treatment of the
disease. The renineangiotensin systemnot only is essential in
cardiovascular haemodynamics, but plays an important role
in the development of CVD. Angiotensin I-converting enzyme
(ACE) is a key component of both the renineangiotensine
aldosterone system (RAAS) and the Kininekallikrein system.5
Angiotensin-converting enzyme is a zinc metallopeptidase
that cleaves the C-terminal dipeptide (HiseLeu) from angio-
tensin 1 and generates a vasoconstrictor, angiotensin II.6
Through protease activity it also inactivates bradykinin,
a potent vasodilator. Due to its role in the RAAS, human
vascular tone and blood salt/water balance have been main-
tained.7 Higher activity of RAAS results in vasoconstriction,
salt water retention, endothelial dysfunction etc which is
detrimental to normal physiology. The ACE gene maps to
chromosome 17q23 spans 21 kb, and comprises 26 exons and
25 introns.8,9 The two major species of ACE mRNA (tran-
scription encompassing exons 1e26, excluding exon 13) and
a 3 kb testicular type ACE mRNA (transcription encompassing
exons 13e26). Exon 26 encodes for the functionally important
membrane anchoring domain of the ACE protein. The activity
of ACE was strongly influenced by a quantitative trait locus
which is in linkage disequilibrium with the Alu insertion/
deletion (I/D) marker10e13 in intron 16. Polymorphism in
intron 16 results in three genotypes e insertion homozygote
(I/I), insertion/deletion heterozygote (I/D) and deletion
homozygote (D/D).14 The differences in the degree of linkage
disequilibrium between this quantitative trait locus and the I/
D polymorphism are cited as a reason for the differences in
the association of the polymorphism with CAD in different
populations.15 The serum ACE levels are determined by the
ACE polymorphism in the following order: DD > I/D > II.12
Association of ACE I/D polymorphism with essential hyper-
tension, myocardial infarction, coronary heart disease,
development of nephropathy in insulin and noninsulin
dependent diabetes mellitus and diabetes mellitus have been
reported.16e20 An insertion/deletion (I/D) polymorphism of the
ACE gene has been proposed as a genetic marker of risk of
coronary heart disease.17 This polymorphism has been
recognized to be a major determinant of plasma ACE activity,
with the highest values found in subjects homozygous for the
D allele and the lowest in subjects homozygous for the I allele;
ID heterozygotes show intermediate values.21 Several studies
have shown that the DD genotype is associated with a higher
risk for myocardial ischaemia (MI) and CAD.17 Some studies
on the association betweenACE genotypes and the risk of CAD
have provided controversial results.18To the best of our knowledge the study is the first to report
on probable association of certain ACE polymorphisms as
predisposing factors in the development of the CAD and their
interactions with relevant biochemical and lifestyle factors in
the general population of Eastern India.2. Materials and methods
2.1. Choice of study cases
Two hundred and seventeen clinically diagnosed cases with
coronary artery diseases were chosen from the outdoor of
Cardiology Department of Ramakrishna Mission Seva Pra-
tishthan. Two hundred and fifty-five age and sex matched
medically diagnosed healthy controls were taken for the
study which were negative for Treadmill test (TMT ve). All
the samples were diagnosed by biochemical tests and other
medical tests like ECG, Echo, Treadmill test. After selection of
the subjects, detailed history regarding their clinical, lifestyle
habits and socioeconomic conditions were collected. Detailed
status of the relevant biochemical parameters were noted
from their recent investigations. All the study subjects were
Bengali, Indian and belonged to the same ethnic group. The
research protocol was approved by the ethical committee of
the institution.
2.2. ACE polymorphism study
2e3 ml blood were collected from each individual in an EDTA
vial. Genomic DNA was extracted from peripheral blood
leukocytes by salting out method.22 Polymerase chain reac-
tion (PCR) detection of the insertion/deletion polymorphism of
the human angiotensin converting enzyme gene (DCP1) i.e.
dipeptidyl carboxypeptidase 1 was done by specific primer
sequences, sense oligo: 50 CTGGAGACCACTCCCATCC1TTCT
30and anti-sense oligo: 50 GATGTGGCCATCACATTCGTCAGAT
30. The DNA was amplified for 30 cycles with denaturation at
94 C for 1 min, annealing at 58 C for 1 min, and extension at
Table 2 e Baseline patient characteristics.
Cases
(N ¼ 217)
p* Controls
(N ¼ 255)
Age (Yrs)
Range 29e81 e 18e66
Average 42.60 40.53
Gender (n, %)
Male 119 (54.8) e 140 (54.90)
Female 98 (45.16) 115 (45.09)
Lifestyle habits (%)
Cigarette smoking 97 (44.7) <0.01 49 (19.21)
Other tobacco habit 129 (59.44) <0.01 199 (78.03)
Alcohol intake 89 (41.01) NS 36 (14.11)
Diabetes (%)a 82 (37.78) <0.001 32 (12.54)
Hypertension (%)b 183 (84.61) <0.01 23 (9.01)
Obesity
BMI (kg/m2)c <25(%) 77 (35.90) e 141 (55.48)
BMI (kg/m2) >25(%) 138 (64.10) <0.01 114 (44.51)
*p: calculated as chi-square test; NS: Non-significant.
i n d i a n h e a r t j o u r n a l 6 4 ( 2 0 1 2 ) 5 7 6e5 8 157872 C for 2 min by Applied Biosystems 2720 Thermal Cycler.
Genotypes of all individuals were noted as DD: 190 bp; ID:
490 bp, 190 bp; II: 490 bp (Fig. 1).13 All samples with the DD
genotype were recheckedwith allele specific primers.13 All the
results were checked twice in double blind method.
2.3. Statistical analysis
To test for significance of observed interactions, likelihood
ratio tests were conducted using a chi-square test. The odd-
ratios for different association models were calculated with
95% confidence interval and simultaneously p values were
calculated. A value of p < 0.05 was considered as statistically
significant. Extent of other risk factors was compared between
cases and controls and across genotype levels. The stepwise
multiple logistic regression analysis was performed with the
SPSS Statistical Package (version 14) for the determination of
the independent risk factors for CAD.a Fasting blood glucose 120 mg/dl.
b Systolic pressure >130 mm Hg; diastolic pressure >80 mm Hg.
c Body mass index.3. Results
The status of total serum cholesterol, HDL cholesterol, LDL
cholesterol and serum triglycerides among the study subjects
are shown in Table 1. Significant associations were found for
these parameters in the development of CAD. Table 2 shows
the different lifestyle as well as demographic characteristics
of the subjects. 44.44% of the cases were found to be smokers
which is much higher than that of the controls (19.21%).
Smoking includes intake of both cigarette and bidi (a dry rolled
temburni leaf containing fine tobacco dust). As expected
intake of other forms of tobacco also found to have significant
association with the CADs. Other form of tobacco includes
catechu, zarda (flavoured tobacco) etc. Though the frequency
of alcohol intakewas higher among the cases than the control,
it did not have any statistical impact on the disease. The
observed data strongly correlates family history and the
development of the disease. Coexistence of diabetes, obesity
and hypertension also elevates the risk of the disease. No
differences in age and sexwere observed among the cases and
controls. We did not find any association of educational and
economic background of the subjects with the disease (data
not shown). Table 3 shows the distribution of different ACE
genotypes and the corresponding allele frequencies amongTable 1 e Distribution of biochemical risk factors among
study subjects.
Cases (N ¼ 217)
[Mean  S.D]
p* Control (N ¼ 255)
[Mean  S.D]
HDL (mg/dl) 49.6  3.2 <0.02 66.2  2.4
LDL (mg/dl) 143  2.4 <0.02 115  3.4
Serum cholesterol
(mg/dl)
188  5.2 <0.05 173.5  3.5
Serum triglyceride
(mg/dl)
157  82.1 <0.02 132.2  2.4
HDL: High density lipoprotein; LDL: Low density lipoprotein.
*p: calculated as chi-square test.
S.D: Standard deviation.the subjects. The frequencies were compatible with Har-
dyeWeinberg equilibrium. It was found that both the ID and
DD genotypes impart statistically significant effect on the
development of CAD (Table 4). The number of D allele carrying
subjects was significantly higher in CADs. D allele was found
to impart more risk of the disease in homozygous form than
the ID genotype. The interactions among different poly-
morphisms of ACE and age, sex, diabetes, hypertension,
family history, different forms of tobacco use, alcohol intake
with the risks of CADs are summarized in Table 5. It was found
that extensive smoking (>35 shots/week) and tobacco intake,
diabetes, hypertension and family history of CAD were
significantly associated with DD and ID genotypes respec-
tively. In short, it was found from the stepwise logistic
regression analysis that D allele of ACE gene was an inde-
pendent risk factor for the CADs (OR: 1.44, 95%CI:
230.12e236.88, p < 0.05).4. Discussion
There have been several studies that have investigated D
allele frequency with coronary artery disease including one
meta-analysis of 118 published studies23 which demonstrated
a modest positive association between ACE-ID and CAD. TheTable 3 e Distribution of ACE genotype and allele
frequencies in the study.
Genotype frequencies Allele frequencies
ID DD II D allele I allele
Case (n) 0.474 0.235 0.29 0.47
H ¼ 0.69
0.37
Control (n) 0.443 0.152 0.40 0.527
H ¼ 1.29
0.62
H ¼ HardyeWeinberg equilibrium.
Table 4 e Distribution of ACE genotypes in the study
subjects (overall).
Genotype Cases
(n,%)
Control
(n,%)
Crude OR
(CI%)
p*
ID 103 (47.46) 113 (44.31) 1.48 (93.28e97.72) <0.99
DD 51 (23.5) 39 (15.29) 2.16 (60.60e67.40) <0.95
II 33 (29.03) 103 (40.39) e e
D allele 205 (47.23) 191 (38.2) 1.44 (230.12e236.88) <0.95
I allele 229 (52.76) 309 (61.8) e e
OR: odd ratio; CI: confidence interval; NS: non-significant.
*p-values obtained through chi-square analysis of the differential
genotypes.
Table 5 e Association of ACE genotypes with other risk factors
Factors ID
Case
(n, %)
Control
(n, %)
OR, 95%CI pa C
(
Sex
Male 58 (26.72) 43 (16.86) 1.83 0.29 23
(1.063e3.170)
Female 50 (23.04) 70 (27.45) 28
Age (years)
45 34 (15.66) 41 (16.07) 0.939 0.838 15
(0.516e1.710)
>45 69 (31.72) 72 (28.23) 36
Other tobacco intake
2e3 s times/day 78 (35.9) 82 (32.15) 1.81 0.007 12
(0.862e3.8)
Never 25 (11.52) 31 (12.15) 39
Smoking
Never 21 (9.67) 37 (14.5) 11
Ex-smokers 35 (16.12) 25 (2.74) 0.42 0.088 12
(0.81e0.99)
35 times/week 31 (14.28) 22 (8.62) 0.57 0.41 10
(0.153e2.147)
>35 times/week 32 (14.74) 29 (11.37) 1.38 0.003 18
(0.057e1.31)
Alcohol intake
Heavy 24 (11.05) 28 (10.98) 0.232 0.049 4
(0.054e0.993)
Occasional 46 (21.19) 36 (14.11) 0.132 0.3 15
(0.057e0.305)
Never 33 (15.2) 49 (19.21) 32
Coexistence of diabetes
Yes 59 (27.18) 22 (8.62) 1.3 0.001 23
(1.153e2.610)
Never 44 (20.27) 91 (35.68) 28
Coexistence of high LDLC
Yes 82 (37.78) 87 (34.11) 0.481 0.35 38
(0.244e0.950)
Never 21 (9.67) 26 (10) 13
Family history of CAD
Yes 81 (37) 30 (11.76) 1.9 0.001 9
(0.006e0.045)
No 22 (10.13) 83 (33) 42
Coexistence of hypertension
Yes 86 (39.63) 23 (9) 1.7 0.001 41
(0.008e1.044)
Never 17 (7.83) 90 (35.29) 10
OR: odd ratio; CI: confidence interval.
a Calculated by c2 analysis comparing genotype distributions among cas
i n d i a n h e a r t j o u rn a l 6 4 ( 2 0 1 2 ) 5 7 6e5 8 1 579meta-analysis highlighted the heterogeneity of the reports
and the lack of information from certain high risk groups such
as East Indian. Reports of ACE-ID and CAD in Indians are
limited to two previous reports one centred in Mumbai24 and
the second in Singapore25 both of which were negative. Few
have also investigated themodification of risk associated with
various forms of tobacco and alcohol consumption and the
geneegene interactions between these polymorphisms
among several population groups worldwide. To the best of
our knowledge our study traces out the same correlations
with the CAD cases of Eastern India for the first time. Our
study shows similar results to two recent studies from
Poland26 and Portugal27 in connection with ACE-D allele.
DD II
ase
n, %)
Control
(n, %)
OR, 95%CI pa Case
(n, %)
Control
(n, %)
(10.59) 21 (8.2) 0.901 0.759 32 (14.7) 78 (30.5)
(0.46e1.754)
(12.9) 18 (7) 31 (14.2) 25 (9.8)
(6.91) 13 (5.09) 0.389 0.182 21 (9.67) 41 (16.07)
(0.182e0.829)
(16.58) 26 (10) 42 (19.35) 62 (24.31)
(5.52) 30 (11.7) 3.191 0.001 32 (14.74) 57 (22.35)
(1.59e6.3)
(17.97) 9 (3.52) 31 (14.28) 46 (18.03)
(5.06) 26 (10.19) 37 (17) 52 (20.39)
(5.52) 5 (1.96) 0.23 0.091 17 (7.83) 21 (8.23)
(0.09e0.56)
(4.6) 1 (0.34) 0.80 0.088 6 (2.76) 15 (5.88)
(1.017e3.62)
(8.29) 7 (2.74) 1.27 0.004 3 (1.38) 15 (5.88)
(0.147e1.563)
(1.84) 2 (0.78) 0.336 0.246 4 (1.87) 11 (4.31)
(0.053e2.122)
(7) 6 (2.3) 0.171 0.4 21 (9.67) 20 (7.9)
(0.069e0.423)
(14.74) 31 (12.15) 45 (20.73) 72 (28.23)
(10.59) 17 (6.66) 1.67 0.008 21 (9.7) 30 (11.78)
(0.313e1.409)
(12.9) 22 (8.6) 42 (19.35) 73 (28.62)
(17.5) 10 (4) 0.288 0.091 21 (10) 21 (8.23)
(0.139e0.597)
(6) 29 (11) 42 (19) 92 (37)
(5) 18 (7.05) 1.6 0.001 10 (4.6) 20 (8)
(0.008e0.044)
(19.35) 21 (8.2) 53 (24.42) 83 (32.5)
(18.89) 7 (2.7) 1.1 0.004 45 (20.73) 15 (5.88)
(1.005e2.06)
(4.6) 32 (12.54) 18 (8.29) 88 (34.5)
e and control subjects.
i n d i a n h e a r t j o u r n a l 6 4 ( 2 0 1 2 ) 5 7 6e5 8 1580associated with CAD, hypertension, smoking, obesity, dia-
betes and dyslipidaemia in their local populations. Risk
factors and as well as genetic factors also play an important
role in the development of coronary artery disease. ACE gene
is significantly up regulated in adipose tissue and it has been
shown before that ACE-D allele is associated with increased
obesity.28,29 In our study, the prevalence of CAD was signifi-
cantly high among the obsessed individuals. As per smoking
and alcohol intake is concerned our results partially support
some of the previous works.30,31 It is a known fact that nico-
tine increases ACE gene expression resulting in increased
plasma and tissue activity of angiotensin II.32 Higher levels of
nicotine were found in tobacco from bidis (26.9 mg/gm) as
compared to cigarettes available in Indian markets (15 mg/
gm). Nicotine concentration in other forms of chewing
tobacco was 3.4 mg/gm.33 We observed significant association
of extensive smoking of cigarettes with the disease in
comparison to the other forms of tobacco. Alcohol intake did
not have any role on the disease development. Further strat-
ification analysis showed significant association between
smoking (>35 shots/week), other tobacco habits with ID and
DD genotypes but no association was found in case of alcohol
intake. Association of the DD genotype of the ACE gene and
myocardial infarction (MI) and CAD has also been reported in
numerous studies.17,34e36 Cambien et al first reported
a significant association between the ACE DD genotype and an
increased risk of myocardial infarction (MI) in Ireland and
France.17 Higher frequency of DD genotypes has also been
observed among Japanese CAD cases.37 Studies on the Indian
population have shown contradictory results. Distribution of
ACE polymorphism varies in different geographical regions
and ethnic groups in India. I allele frequency was significantly
higher (p< 0.05) in Dogras, Assamese and Kumaonese and the
D allele was higher in Punjabis.38 The aim of our study was to
look for the polymorphisms of ACE in the development of
coronary artery disease in the general population of Eastern
India. We found higher D allele frequency and DD [OR ¼ 2.16,
95%CI ¼ 60.60e67.40 (p < 0.95)] and ID [OR ¼ 1.48, 95%
CI ¼ 93.28e97.72 (p < 0.99)] genotypes were significantly
higher in the study cases as compared to the controls. Coex-
istence of diabetes and hypertension has been reported to be
risk factor for the development of CAD.39 Both hypertension
and diabetes were more significantly associated with ID and
DD genotypes in our study. Family history of CHD has been
well recognized in some studies.40,41 We have also observed
significantly higher prevalence of ID andDD genotypes among
the cases who had strong history of development of CAD in
their first degree relatives than the controls. As expected, the
LDL, HDL, serum cholesterol, serum triglyceride were found to
have statistical correlations with the diseases at different
significant levels. Some have agreed that high LDL cholesterol
and low HDL cholesterol are independent risk factors for
CVD31,42,43 and our study also supports it. In summary, ID and
DD genotypes of ACE gene came out to be predisposing factors
for the CAD cases in our study population. In spite of several
precautions our study has certain limitations. Our study was
hospital-based and could result in biased selection in place of
random sampling. It has been suggested that studies with
hospital controls can provide lower risk estimates, since
diseases of controls could be associated with thepolymorphisms under study. The insertion/deletion poly-
morphism of ACE gene, being a low-penetrancemutationmay
be in linkage disequilibrium with another functional variant
and analysis of multiple genetic markers in the context of
environmental factors is required to increase the probability
of providing clinically useful information. But, the paper
attempts to establish the sole role of the concerned poly-
morphism in developing CAD. On the other hand, inclusion of
additional subjects would enhance this study especially in
light of the heterogeneity of worldwide reports including two
negative reports with East Indian subjects. Though 117 indi-
viduals are sufficient to represent a population status, the
associations and the underlying mechanisms of lifestyle
factors with the metabolic enzymes gene polymorphisms still
need further study with large-scale (population-based)
samples and modified designs.Conflicts of interest
All authors have none to declare.
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